Proteolytic Enzymes Activities in Patients After Myocardial Infarction Correlate with Serum Concentration of TGF-β

Myocardial infarction (MI) is caused by occlusion of coronary artery and insufficient oxygen supply to a certain area of myocardium. Its necrosis appears as a result of MI. The process of tissue repair after MI is very complicated and it is influenced by numerous factors, including growth factors and proteolytic enzymes. The aim of the study was to determine serum transforming growth factor β (TGF-β) concentration on day 2 and 7 after MI and to asses the relationship of this growth factor with serum proteolytic activity of collagenase and elastase. In addition, the effect of fibrynolytic treatment on these factors was evaluated. About 100 patients with MI were enrolled to the study. The control group consisted of 50 healthy individuals. We observed that TGF-β1 concentration correlated positively with collagenase activity on the second day after MI and that it also correlated positively with elastase activity on day 2 and 7 after MI. Moreover, treatment with streptokinase (SK) caused a significant increase of TGF-β serum concentration. Our data indicate that TGF-β1 may be one of the factors involved in tissue repair process after MI. Its effect seems to be mediated by collagenase and elastase and may change with the time that elapsed after MI.

[1]  S. Kunkel,et al.  Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. , 1986, American heart journal.

[2]  H. Lodish,et al.  Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.

[3]  K. Ohlsson,et al.  The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes. , 2009, Scandinavian journal of haematology.

[4]  A. Desmoulière,et al.  Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines. , 1994, Cell motility and the cytoskeleton.

[5]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.

[6]  G Olivetti,et al.  Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. , 1990, Circulation research.

[7]  K. Weber,et al.  Cardiac interstitium in health and disease: the fibrillar collagen network. , 1989, Journal of the American College of Cardiology.

[8]  H. Lodish,et al.  Role of Transforming Growth Factor in Human Disease , 2000 .

[9]  E. Ruoslahti,et al.  Transforming growth factor-β regulates production of proteoglycans by mesangial cells , 1990 .

[10]  Y. Sun,et al.  Cardiac remodeling by fibrous tissue after infarction in rats. , 2000, The Journal of laboratory and clinical medicine.

[11]  S. Takahashi,et al.  Collagen degradation in ischaemic rat hearts. , 1990, The Biochemical journal.

[12]  R. Chamuleau,et al.  Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulin , 1997 .

[13]  P. Libby,et al.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. , 1999, Circulation.

[14]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[15]  R. Perez-Tamayo,et al.  The distribution of collagenase in normal rat tissues. , 1975, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  D. Danielpour.  Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. , 1993, Journal of immunological methods.

[17]  W. Kübler,et al.  Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart , 1997, Pflügers Archiv.

[18]  K. Weber,et al.  Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. , 1996, Journal of molecular and cellular cardiology.

[19]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M J Banda,et al.  Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.

[21]  M. J. Ravitz,et al.  Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. , 1997, Advances in cancer research.

[22]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[23]  G. Gabbiani,et al.  Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[24]  H. Ristow.  BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Daemen,et al.  The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.

[26]  Richard T. Lee,et al.  Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.